Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
CSL Behring
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Men or women, at least 18 years of age, with evidence of myocardial necrosis in a clinical setting consistent with a type I (spontaneous) acute myocardial infarction (AMI), in the last week.
You may not be if
Ongoing hemodynamic instability
Evidence of hepatobiliary disease
Evidence of chronic kidney disease (CKD) (Stage III, IV, or V), defined as moderate or severe renal impairment or if subject is receiving dialysis
Evidence of unstable renal function
History of acute kidney injury after previous exposure to an intravenous contrast agent.
Known history of allergies, hypersensitivity or deficiencies to CSL112 or any of its components
Other severe comorbid condition, concurrent medication, or other issue that renders the subject unsuitable for participation in the study
Clareo Health | A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
